Fidelity Investments’s Adamas Pharmaceuticals ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,449,340
| Closed | -$26.8M | – | 5218 |
|
|
2021
Q3 | $26.8M | Buy |
5,449,340
+176,940
| +3% | +$859K | ﹤0.01% | 1694 |
|
|
2021
Q2 | $27.8M | Buy |
5,272,400
+141,677
| +3% | +$733K | ﹤0.01% | 1699 |
|
|
2021
Q1 | $24.6M | Buy |
+5,130,723
| New | +$26.8M | ﹤0.01% | 1717 |
|
|
2020
Q1 | – | Sell |
-300
| Closed | -$1K | – | 4453 |
|
|
2019
Q4 | $1K | Buy |
+300
| New | +$1.44K | ﹤0.01% | 3719 |
|
|
2019
Q2 | – | Sell |
-125
| Closed | -$1K | – | 4326 |
|
|
2019
Q1 | $1K | Buy |
+125
| New | +$1.12K | ﹤0.01% | 3547 |
|
|
2018
Q4 | – | Sell |
-323,869
| Closed | -$6.48M | – | 4347 |
|
|
2018
Q3 | $6.48M | Sell |
323,869
-749,833
| -70% | -$17.6M | ﹤0.01% | 2067 |
|
|
2018
Q2 | $27.7M | Sell |
1,073,702
-339,500
| -24% | -$9.4M | ﹤0.01% | 1557 |
|
|
2018
Q1 | $33.8M | Sell |
1,413,202
-116,202
| -8% | -$3.66M | ﹤0.01% | 1474 |
|
|
2017
Q4 | $51.8M | Sell |
1,529,404
-662,077
| -30% | -$18.5M | 0.01% | 1277 |
|
|
2017
Q3 | $46.4M | Sell |
2,191,481
-272,700
| -11% | -$5M | 0.01% | 1331 |
|
|
2017
Q2 | $43.1M | Hold |
2,464,181
| – | – | 0.01% | 1350 |
|
|
2017
Q1 | $43.1M | Sell |
2,464,181
-269,800
| -10% | -$4.6M | 0.01% | 1378 |
|
|
2016
Q4 | $46.2M | Hold |
2,733,981
| – | – | 0.01% | 1342 |
|
|
2016
Q3 | $44.9M | Sell |
2,733,981
-162,500
| -6% | -$2.47M | 0.01% | 1348 |
|
|
2016
Q2 | $43.9M | Sell |
2,896,481
-70,000
| -2% | -$1.15M | 0.01% | 1331 |
|
|
2016
Q1 | $42.9M | Buy |
2,966,481
+205,900
| +7% | +$3.47M | 0.01% | 1313 |
|
|
2015
Q4 | $78.2M | Hold |
2,760,581
| – | – | 0.01% | 1067 |
|
|
2015
Q3 | $46.2M | Buy |
2,760,581
+87,125
| +3% | +$1.98M | 0.01% | 1286 |
|
|
2015
Q2 | $70.1M | Buy |
2,673,456
+79,189
| +3% | +$1.54M | 0.01% | 1193 |
|
|
2015
Q1 | $45.4M | Buy |
2,594,267
+601,840
| +30% | +$10.3M | 0.01% | 1379 |
|
|
2014
Q4 | $34.6M | Buy |
1,992,427
+468,914
| +31% | +$7.11M | ﹤0.01% | 1498 |
|
|
2014
Q3 | $28.4M | Buy |
1,523,513
+223,772
| +17% | +$3.85M | ﹤0.01% | 1580 |
|
|
2014
Q2 | $23.8M | Buy |
+1,299,741
| New | +$23.3M | ﹤0.01% | 1717 |
|
Fidelity Investments's ADMS Position: Q4 2021 in Review
Fidelity Investments sold out of Adamas Pharmaceuticals (ADMS) in Q4 2021, closing a stake of 5,449,340 shares — an estimated $26.8M sold.
Fidelity Investments first reported a position in ADMS in Q2 2014 and held it in 23 quarters. The position peaked at $78.2M in Q4 2015. 0 funds tracked by Wall St. Rank hold ADMS as of Q4 2021.
- Fidelity Investments reported no remaining Adamas Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Fidelity Investments sold 5,449,340 Adamas Pharmaceuticals shares in Q4 2021, an estimated $26.8M.
- Fidelity Investments first reported a position in Adamas Pharmaceuticals in Q2 2014 and held it in 23 quarters.
- Fidelity Investments's Adamas Pharmaceuticals position peaked at $78.2M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q4 2021.
Based on Fidelity Investments's 13F filing for Q4 2021, filed 14 Feb 2022.